Approximately 4 million people worldwide currently suffer from Parkinson's disease (PD), and this number is only expected to increase. The most frequent genetic causes of the illness are mutations in the gene responsible for controlling the production of protein LRRK2, which includes two enzymes: a kinase and a GTPase. Because this kinase is at the root of neuronal problems, kinase inhibitors have already been clinically tested. However, these inhibitors eventually cause lung and kidney problems, making it imperative for scientists to seek alternative solutions.
An international group of researchers has unraveled the workings of an essential mechanism in 'Parkinson's protein' LRRK2. Their study demonstrates a direct link between the protein's 'dimerization' - two copies that are bound together -and mutations that lead to Parkinson's disease. This process could eventually lead to a promising therapy route. This research has been published in the leading academic journal Nature Communications.
Parkinson's protein comes in a single or doubled state. Researchers sought a better understanding of LRRK2's complex structure. It is already known that the kinase portion of the protein is active in the protein's 'dimeric' or 'double' state, which involves two identical copies of the protein bound together. Using this information as a starting point, the team investigated how this binding is established. To do so, the scientists observed similar proteins occurring in certain bacteria.
They show that oligomerization of a homologous bacterial Roco protein depends on the nucleotide load. The protein is mainly dimeric in the nucleotide-free and GDP-bound states, while it forms monomers upon GTP binding, leading to a monomer-dimer cycle during GTP hydrolysis. An analogue of a PD associated mutation stabilizes the dimer and decreases the GTPase activity.
Senior author said: "The GTPase enzyme, a component of LRRK2, regulates the state of the entire protein. In doing so, it determines whether a LRRK2 protein is in its inactive 'single' state, or its active 'double' state. In addition, we saw a clear link between the protein dimerization and genetic mutations in Parkinson's disease. As a result, this regulation process constitutes an attractive new target for future drug development."
'
http://www.vib.be/en/news/Pages/Newly-described-process-in-Parkinson%E2%80%99s-protein-as-a-potential-new-therapy-route.aspx
https://www.nature.com/articles/s41467-017-01103-4
Latest News
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Mapping microbiome in metas…
By newseditor
Posted 22 Apr
Other Top Stories
Long non-coding RNA regulation of tau translation in Alzheimer's
Read more
Cell surface has sugar-coated RNA
Read more
Sulfide catabolism ameliorates hypoxic brain injury
Read more
Plants response to nitrogen deficiency
Read more
Impact of DNA methylation on 3D genome structure
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar